Business Context and Reporting Period
This Form 8-K Current Report was filed by Core Scientific, Inc. on June 14, 2024. The filing discloses the execution of a new employment agreement and equity grants for Adam Sullivan, who serves as the Company's President and Chief Executive Officer.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation arrangements.
Material Changes and Executive Compensation
On June 14, 2024, the Company entered into a new employment agreement with CEO Adam Sullivan, effective immediately. Key terms include:
- Base Salary: $625,000 annually.
- Annual Incentive: Target of 125% of base salary ($781,250) for 2024, subject to performance criteria.
- Legal Fee Reimbursement: $80,000 for fees incurred during negotiation.
- Severance (Outside Protection Period): 18 months of base salary, pro-rata bonus, COBRA coverage, and accelerated vesting of the 2024 Equity Grant upon termination without Cause or resignation for Good Reason.
- Severance (During Protection Period): Lump-sum payment equal to two times the sum of base salary and target annual bonus, plus pro-rata bonus, COBRA, and accelerated vesting.
Equity Grants
Concurrent with the agreement, Mr. Sullivan received the following 2024 Equity Grants under the Core Scientific, Inc. 2024 Stock Incentive Plan:
- Special One-Time Grant: 2,867,521 time-based Restricted Stock Units (RSUs) vesting in four equal tranches starting January 23, 2025.
- Regular Annual Grant (Time-Based): 716,881 RSUs with one-third vesting on January 23, 2025, and the remainder vesting quarterly through December 31, 2026.
- Regular Annual Grant (Performance-Based): 238,961 RSUs eligible to vest over three years (2024-2026) subject to performance goals.
Outlook, Risks, and Contingencies
The filing does not provide updated financial guidance, outlook, or general risk factors. The primary contingency noted is the vesting of equity awards, which is subject to the "Service Condition" (continued employment) and, for performance-based units, the attainment of specific performance goals.
Investor Verification Checklist
- Verify the definition of the "Protection Period" in the full Employment Agreement (Exhibit 10.1) to understand the conditions triggering the enhanced severance package.
- Review the specific performance criteria required to achieve the 125% annual incentive target and the performance-based RSUs.
- Confirm the total number of shares authorized under the 2024 Stock Incentive Plan to assess the dilution impact of the 3,823,363 total RSUs granted.
- Check subsequent filings for any updates to the Company's liquidity position, as this 8-K does not address financial health.